| First Author | Fraszczak J | Year | 2019 |
| Journal | Leukemia | Volume | 33 |
| Issue | 1 | Pages | 110-121 |
| PubMed ID | 29925903 | Mgi Jnum | J:270034 |
| Mgi Id | MGI:6274849 | Doi | 10.1038/s41375-018-0166-1 |
| Citation | Fraszczak J, et al. (2019) Reduced expression but not deficiency of GFI1 causes a fatal myeloproliferative disease in mice. Leukemia 33(1):110-121 |
| abstractText | Growth factor independent 1 (Gfi1) controls myeloid differentiation by regulating gene expression and limits the activation of p53 by facilitating its de-methylation at Lysine 372. In human myeloid leukemia, low GFI1 levels correlate with an inferior prognosis. Here, we show that knockdown (KD) of Gfi1 in mice causes a fatal myeloproliferative disease (MPN) that could progress to leukemia after additional mutations. Both KO and KD mice accumulate myeloid cells that show signs of metabolic stress and high levels of reactive oxygen species. However, only KO cells have elevated levels of Lysine 372 methylated p53. This suggests that in contrast to absence of GFI1, KD of GFI1 leads to the accumulation of myeloid cells because sufficient amount of GFI1 is present to impede p53-mediated cell death, leading to a fatal MPN. The combination of myeloid accumulation and the ability to counteract p53 activity under metabolic stress could explain the role of reduced GF1 expression in human myeloid leukemia. |
